|
RS50101B
(sr)
|
1996-02-24 |
2009-01-22 |
Boehringer Ingelheim International Gmbh., |
Farmaceutski preparati za imunomodulaciju
|
|
DE19803453A1
(de)
|
1998-01-30 |
1999-08-12 |
Boehringer Ingelheim Int |
Vakzine
|
|
DE69910743T2
(de)
*
|
1998-02-25 |
2004-07-08 |
The Government Of The United States, As Represented By The Secretary Of The Army |
Verwendung von hautpenetrationsförderern und für die zerstörung der oberen hautschichten geeigneten mitteln zur erhöhung der durch adp-ribosylating-exotoxin induzierten immunantwort
|
|
DE69837350T2
(de)
*
|
1998-04-20 |
2007-11-29 |
Torrey Pines Institute For Molecular Studies, San Diego |
Topische immunostimulierung zur induzierung der migration der langerhanszellen
|
|
EP1150710B1
(en)
*
|
1999-02-17 |
2010-04-21 |
Csl Limited |
Immunogenic complexes and methods relating thereto
|
|
DE19909503A1
(de)
*
|
1999-03-04 |
2000-09-07 |
Boehringer Ingelheim Int |
Tumorassoziiertes Antigen
|
|
US6809179B1
(en)
|
1999-08-04 |
2004-10-26 |
Boehringer Ingelheim International Gmbh |
Tumor-associated antigen (R11)
|
|
AT408721B
(de)
*
|
1999-10-01 |
2002-02-25 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung enthaltend ein antigen
|
|
AT409085B
(de)
*
|
2000-01-28 |
2002-05-27 |
Cistem Biotechnologies Gmbh |
Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
|
|
US20020009491A1
(en)
*
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
AT409762B
(de)
*
|
2000-04-13 |
2002-11-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung von zytokin sekretierenden zellen
|
|
AT410173B
(de)
|
2000-06-08 |
2003-02-25 |
Cistem Biotechnologies Gmbh |
Antigene zusammensetzung
|
|
KR20020014459A
(ko)
*
|
2000-08-18 |
2002-02-25 |
서진호 |
양이온성 아미노산이 부가된 융합단백질 및 이를 이용한생물공정의 개선방법
|
|
EP1347776A2
(en)
*
|
2001-01-05 |
2003-10-01 |
Intercell Biomedizinische Forschungs- und Entwicklungs AG |
Anti-inflammatory use of polycationic compounds
|
|
US7244438B2
(en)
|
2001-01-05 |
2007-07-17 |
Intercell Ag |
Uses for polycationic compounds
|
|
EP1347775B1
(en)
*
|
2001-01-05 |
2016-11-30 |
Valneva Austria GmbH |
Uses for polycationic compounds as vaccine adjuvants
|
|
AT410798B
(de)
|
2001-01-26 |
2003-07-25 |
Cistem Biotechnologies Gmbh |
Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
|
|
FR2824326B1
(fr)
*
|
2001-05-04 |
2004-03-19 |
Commissariat Energie Atomique |
Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
|
|
AU2002358616A1
(en)
*
|
2001-12-07 |
2003-06-17 |
Intercell Ag |
Immunostimulatory oligodeoxynucleotides
|
|
US20050221350A1
(en)
*
|
2002-05-29 |
2005-10-06 |
Toni Weinschenk |
Method for identifying immunoreactive peptides
|
|
US7528223B2
(en)
|
2002-07-24 |
2009-05-05 |
Intercell Ag |
Antigens encoded by alternative reading frames from pathogenic viruses
|
|
JP2006504687A
(ja)
|
2002-09-13 |
2006-02-09 |
インターツェル・アクチェンゲゼルシャフト |
Ｃ型肝炎ウイルスペプチドの単離方法
|
|
AU2003274011B2
(en)
|
2002-10-15 |
2010-03-04 |
Intercell Ag |
Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
|
|
PL1601770T3
(pl)
|
2003-03-04 |
2010-02-26 |
Intercell Ag |
Antygeny Streptococcus pyogenes
|
|
CA2517673C
(en)
|
2003-03-24 |
2013-08-13 |
Intercell Ag |
Improved vaccines for preventing viral infection
|
|
DE602004024179D1
(de)
|
2003-03-31 |
2009-12-31 |
Intercell Ag |
Staphylococcus epidermidis antigene
|
|
EP2311988A1
(en)
|
2003-04-15 |
2011-04-20 |
Intercell AG |
S. pneumoniae antigens
|
|
CN101864431A
(zh)
|
2003-05-07 |
2010-10-20 |
英特塞尔股份公司 |
无乳链球菌抗原ⅰ和ⅱ
|
|
EP1629005A2
(en)
|
2003-05-30 |
2006-03-01 |
Intercell AG |
Enterococcus antigens
|
|
JP4734241B2
(ja)
|
2003-07-11 |
2011-07-27 |
インターツェル・アクチェンゲゼルシャフト |
Ｈｃｖワクチン
|
|
EP1722819B1
(en)
|
2004-03-12 |
2007-12-26 |
Intercell AG |
Method for solubilising peptide mixtures
|
|
DE102004038134B4
(de)
|
2004-08-05 |
2013-07-25 |
Johann Wolfgang Goethe-Universität Frankfurt am Main |
Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung
|
|
ES2344739T3
(es)
|
2004-09-24 |
2010-09-06 |
Intercell Ag |
Proteina capsidial vp1 modificada del parvovirus b19.
|
|
CA2583026A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Intercell Ag |
Hcv vaccines for chronic hcv patients
|
|
WO2006112477A1
(ja)
*
|
2005-04-20 |
2006-10-26 |
Taiho Pharmaceutical Co., Ltd. |
アジュバントとしてのポリアミノ酸
|
|
EP1887084A1
(en)
*
|
2006-08-10 |
2008-02-13 |
International Investment and Patents SA |
Plasmids with immunological action
|
|
US8129165B2
(en)
|
2006-09-15 |
2012-03-06 |
Intercell Ag |
Borrelia antigens
|
|
JP2008174490A
(ja)
*
|
2007-01-18 |
2008-07-31 |
Nitto Denko Corp |
抗原性ペプチドを主成分とする薬剤
|
|
CA2685805A1
(en)
|
2007-05-02 |
2008-11-13 |
Intercell Ag |
Klebsiella antigens
|
|
KR100748265B1
(ko)
*
|
2007-06-15 |
2007-08-10 |
(주)성문엔지니어링 |
공동주택에 배선된 전선의 합선방지구조
|
|
AU2008265218A1
(en)
|
2007-06-18 |
2008-12-24 |
Intercell Ag |
Chlamydia antigens
|
|
PT2173376E
(pt)
|
2007-08-02 |
2015-07-30 |
Biondvax Pharmaceuticals Ltd |
Vacinas de influenza multiepitópicas multiméricas
|
|
RU2494737C2
(ru)
*
|
2008-03-27 |
2013-10-10 |
Нестек С.А. |
Способы увеличения абсорбции пептидов, пептидомиметиков и других субстратов гастроинтестинального транспортного белка
|
|
AU2009323682A1
(en)
|
2008-12-03 |
2010-06-10 |
Protea Vaccine Technologies Ltd. |
Glutamyl tRNA synthetase (GtS) fragments
|
|
US8617574B2
(en)
|
2009-02-13 |
2013-12-31 |
Valneva Austria Gmbh |
Nontypable Haemophilus influenzae antigens
|
|
BR112012004276A2
(pt)
*
|
2009-08-27 |
2017-10-24 |
Novartis Ag |
adjuvante compreendendo alumínio, oligonucleotídeo e policátion
|
|
US9700650B2
(en)
|
2009-11-09 |
2017-07-11 |
Spotlight Technology Partners Llc |
Polysaccharide based hydrogels
|
|
NZ599527A
(en)
|
2009-11-09 |
2014-04-30 |
Spotlight Technology Partners Llc |
Fragmented hydrogels
|
|
WO2011067758A2
(en)
|
2009-12-02 |
2011-06-09 |
Protea Vaccine Technologies Ltd. |
Immunogenic fragments and multimers from streptococcus pneumoniae proteins
|
|
US8765148B2
(en)
|
2010-02-19 |
2014-07-01 |
Valneva Austria Gmbh |
1C31 nanoparticles
|
|
CA2828068C
(en)
|
2011-02-22 |
2019-03-19 |
Biondvax Pharmaceuticals Ltd. |
Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
|
|
RU2478399C2
(ru)
*
|
2011-06-16 |
2013-04-10 |
Государственное научное учреждение Всероссийский научно-исследовательский институт бруцеллеза и туберкулеза животных Российской академии сельскохозяйственных наук (ГНУ ВНИИБТЖ Россельхозакадемии) |
Способ получения специфического иммуномодулятора
|
|
US20140271723A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Saint Louis University |
Adjuvant compositions and methods of using thereof
|
|
CA3116265A1
(en)
|
2014-10-07 |
2016-04-14 |
Cytlimic Inc. |
Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
|
|
CN107847572A
(zh)
|
2015-05-13 |
2018-03-27 |
艾吉纳斯公司 |
用于癌症治疗和预防的疫苗
|
|
EP3392291B1
(en)
*
|
2015-12-16 |
2020-08-05 |
Huvet Bio, Inc. |
Vaccine adjuvant composition based on amphiphilic polyamino acid polymer, containing squalene
|
|
US12065699B2
(en)
|
2016-03-15 |
2024-08-20 |
Repertoire Genesis Incorporation |
Monitoring and diagnosis for immunotherapy, and design for therapeutic agent
|
|
US20200282032A1
(en)
*
|
2016-05-27 |
2020-09-10 |
Etubics Corporation |
Neoepitope vaccine compositions and methods of use thereof
|
|
JP6998880B2
(ja)
*
|
2016-10-11 |
2022-02-10 |
サイトリミック株式会社 |
医薬
|
|
CN107469067B
(zh)
*
|
2017-09-05 |
2018-06-19 |
浙江大学 |
一种多肽及其改造体在制备免疫调节药物中的应用
|
|
CN112218883A
(zh)
|
2018-04-26 |
2021-01-12 |
艾吉纳斯公司 |
热休克蛋白结合肽组合物及其使用方法
|
|
CN110870913A
(zh)
*
|
2018-08-31 |
2020-03-10 |
成都夸常奥普医疗科技有限公司 |
氨基酸类营养素作为疫苗佐剂的应用以及包含氨基酸营养素作为佐剂的疫苗
|
|
CN110870912A
(zh)
*
|
2018-08-31 |
2020-03-10 |
成都夸常奥普医疗科技有限公司 |
亚甲蓝类染料作为疫苗佐剂的应用、包含该佐剂的疫苗及其应用
|
|
CN117860879A
(zh)
*
|
2024-01-10 |
2024-04-12 |
广州医科大学附属肿瘤医院 |
一种纳米疫苗递送系统及其制备方法和应用
|